Daniel J Wu1,2, Athena Aktipis3, John W Pepper2,4. 1. Department of Biology, Stanford University, Stanford, CA, USA. 2. Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA. 3. Arizona State University, Biodesign Institute, Tempe, AZ, USA. 4. Santa Fe Institute, Santa Fe, NM, USA.
Abstract
BACKGROUND AND OBJECTIVES: Several major risk factors for cancer involve vascular oversupply of energy to affected tissues. These include obesity, diabetes and chronic inflammation. Here, we propose a potential mechanistic explanation for the association between energy oversupply and cancer risk, which we call the metabolic cancer suppression hypothesis: We hypothesize that oncogenesis is normally suppressed by organismal physiology that regulates and strictly limits normal energy supply to somatic cells, and that this protection is removed by abnormal oversupply of energy. METHODOLOGY: We evaluate this hypothesis using a computational model of somatic cell evolution to simulate experimental manipulation of the vascular energy supply to a tissue. The model simulates the evolutionary dynamics of somatic cells during oncogenesis. RESULTS: In our simulation experiment, we found that under plausible biological assumptions, elevated energy supply to a tissue led to the evolution of elevated energy uptake by somatic cells, leading to the rapid evolution of both defining traits of cancer cells: hyperproliferation, and tissue invasion. CONCLUSIONS AND IMPLICATIONS: Our results support the hypothesis of metabolic cancer suppression, suggesting that vascular oversupply of energetic resources to somatic cells removes normal energetic limitations on cell proliferation, and that this accelerates cellular evolution toward cancer. Various predictions of this hypothesis are amenable to empirical testing, and have promising implications for translational research toward clinical cancer prevention. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health 2019.
BACKGROUND AND OBJECTIVES: Several major risk factors for cancer involve vascular oversupply of energy to affected tissues. These include obesity, diabetes and chronic inflammation. Here, we propose a potential mechanistic explanation for the association between energy oversupply and cancer risk, which we call the metabolic cancer suppression hypothesis: We hypothesize that oncogenesis is normally suppressed by organismal physiology that regulates and strictly limits normal energy supply to somatic cells, and that this protection is removed by abnormal oversupply of energy. METHODOLOGY: We evaluate this hypothesis using a computational model of somatic cell evolution to simulate experimental manipulation of the vascular energy supply to a tissue. The model simulates the evolutionary dynamics of somatic cells during oncogenesis. RESULTS: In our simulation experiment, we found that under plausible biological assumptions, elevated energy supply to a tissue led to the evolution of elevated energy uptake by somatic cells, leading to the rapid evolution of both defining traits of cancer cells: hyperproliferation, and tissue invasion. CONCLUSIONS AND IMPLICATIONS: Our results support the hypothesis of metabolic cancer suppression, suggesting that vascular oversupply of energetic resources to somatic cells removes normal energetic limitations on cell proliferation, and that this accelerates cellular evolution toward cancer. Various predictions of this hypothesis are amenable to empirical testing, and have promising implications for translational research toward clinical cancer prevention. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health 2019.
Entities:
Keywords:
cancer; cancer prevention; cell energetics; cell metabolism; oncogenesis
Authors: Pär Stattin; Ove Björ; Pietro Ferrari; Annekatrin Lukanova; Per Lenner; Bernt Lindahl; Göran Hallmans; Rudolf Kaaks Journal: Diabetes Care Date: 2007-03 Impact factor: 19.112
Authors: Stephen D Hursting; Sarah M Smith; Laura M Lashinger; Alison E Harvey; Susan N Perkins Journal: Carcinogenesis Date: 2009-12-07 Impact factor: 4.944
Authors: C Athena Aktipis; Amy M Boddy; Gunther Jansen; Urszula Hibner; Michael E Hochberg; Carlo C Maley; Gerald S Wilkinson Journal: Philos Trans R Soc Lond B Biol Sci Date: 2015-07-19 Impact factor: 6.237
Authors: Steven C Moore; I-Min Lee; Elisabete Weiderpass; Peter T Campbell; Joshua N Sampson; Cari M Kitahara; Sarah K Keadle; Hannah Arem; Amy Berrington de Gonzalez; Patricia Hartge; Hans-Olov Adami; Cindy K Blair; Kristin B Borch; Eric Boyd; David P Check; Agnès Fournier; Neal D Freedman; Marc Gunter; Mattias Johannson; Kay-Tee Khaw; Martha S Linet; Nicola Orsini; Yikyung Park; Elio Riboli; Kim Robien; Catherine Schairer; Howard Sesso; Michael Spriggs; Roy Van Dusen; Alicja Wolk; Charles E Matthews; Alpa V Patel Journal: JAMA Intern Med Date: 2016-06-01 Impact factor: 21.873
Authors: Rumen L Kostadinov; Mary K Kuhner; Xiaohong Li; Carissa A Sanchez; Patricia C Galipeau; Thomas G Paulson; Cassandra L Sather; Amitabh Srivastava; Robert D Odze; Patricia L Blount; Thomas L Vaughan; Brian J Reid; Carlo C Maley Journal: PLoS Genet Date: 2013-06-13 Impact factor: 5.917